Synthesis of tetrahydroquinoline derivatives from α-CF3-N- arylaldimine and vinyl ethers

Tetrahedron Letters

Volumn 39, Issue 32, 1998, Pages 5765-5768

  Crousse, Benoît ^a   Bégué, Jean Pierre ^a   Bonnet Delpon, Danièle ^a  

^a CNRS   (France)

Author keywords

aza Diels Alder; Lewis acids, vinyl ethers; CF3 N Arylaldimine

Indexed keywords

QUINOLINE DERIVATIVE; VINYL DERIVATIVE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYSIS; MOLECULAR DYNAMICS; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; SYNTHESIS;

EID: 0032490906     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(98)01202-7     Document Type: Article

References (30)

1. [1] a) Johnson, J.V.; Rauckman, S.; Baccanari, P.D., Roth, B. J. Med. Chem., 1989;32:1942-1949.
2. b) Carling, R.W.; Leeson, P.D.; Moseley, A.M.; Baker, R.; Foster, A.C.; Grimwood, S.; Kemp, J.A.; Marshall G.R. J. Med. Chem., 1992;35:1942-1953.
3. c) Leeson, P.D.; Carling, R.W.; Moore, K.W.; Moseley, A.M.; Smith, J.D.; Stevenson G.; Chan, T.; Baker, R.; Foster, A.C.; Grimwood, S.; Kemp, J.A.; Marshall G.R.; Hoogsteen, K., J. Med. Chem., 1992;35:1954-1968.
4. d) Carling, R.W.; Leeson, P.D.; Moselay, A.M.; Smith, J.D.; Saywell, K.; Trickelbank, M.D.; Kemp, J.A.; Marshall, G.R.; Foster, A.C.; Grimwood, S. Bioorganic & Medicinal Chemistry Letters, 1993;3:65-70.
5. [2] Weinreb, S.M. Comprehensive Organic Synthesis, Trost, B.M., Fleming, I., Eds., Pergamon: Oxford, 1991, Vol.5,401
6. [3] Boger, D.L.; Weinreb, S.M. Hetero Diels-Alder Methodology in Organic Synthesis, academic: San Diego, 1987, Chaps.2 and 9.
7. [4] Nomura, Y.; Kimura, M.; Takeuchi, Y.; Tomoda, S. Chemistry Letters, 1978:267-270.
8. [5] Boger, D.L. Tetrahedron, 1983; 39:2869-2939.
9. [6] Kametani, T.; Takeda, H.; Suzuki, Y.; Honda, T. Heterocycles, 1984;22:275-276.
10. [7] Kametani, T.; Takeda, H.; Suzuki, Y.; Kasai, H.; Honda, T. Heterocycles, 1986; 24: 3385-3395.
11. [8] Koichi, N.; Takanori, S. Heterocycles, 1993; 35: 1039-1053.
12. [9] Lucchim, V.; Prato, M.; Scorrano, G.; Tecilla, P. J. Org. Chem., 1988, 53:2251-2258.
13. [10] Lucchim, V.; Prato, M.; Scorrano, G.; Stivanello, M.; Valle, G. J. Chem. Soc. Perkin Trans. 2, 1992: 259-266.
14. [11] Borrione, E.; Lucchini, V.; Prato, M.; Scorrano, G.:, Stivanello, M. .J. Heterocyclic. Chem., 1988;25:1831-1833.
15. [12] Borrione, E.; Prato, M.; Scorrano, G.; Stivanello, M.; Lucchini, V.; Valle, G. J. Chem. Soc. Perkin Trans, 1, 1989:2245-2250.
16. [13] Povarov, L.S. Russ. Chem. Rev., Engl. Transl, 1967; 36:656-675.
17. [14] Makioka, Y; Shindo, T.; Taniguchi, Y.; Takaki, K.; Fujiwara, Y. Synthesis, 1995;801-804.
18. [15] Kobayashi, S.; Ishitani, H.; Nagayama, S. Chemistry Letters, 1995;423-424.
19. [16] Kobayashi, S.; Ishitani, H.; Nagayama, S. Synthesis, 1995;1195-1202.
20. [17] Annunziata, R.; Cinquini, M.; Cozzi, F.; Molteni, V.; Schupp, O., Tetrahedron, 1997;28:9715-9726.
21. [18] a) Organofluorine Compounds in Medecinal Chemistry and Biochemical Applications, Filler, R.; Kobayashi, Y.; Yagupolski, L., 1993; Eds Elsevier, Amsterdam.
22. b) Biomedical Frontiers of Fluorine Chemistry, Ojima, I.; McCarthy, J.R.; Welch, J.T. Eds.A.C.S.:Washington, D.C., 1996;228.
23. c) Edwards, P.N. Use of Fluorine in Chemotherapy. In Organofluorine Chemistry: Principles and commercial Applications, Banks, R.E.; Tatlow, J.C., Plenum Press, 1994, N.Y., 501-541.
24. [19] a) Linderman, R.J.; Jamois, E.A. J. Fluorine Chem.,1991;53:79-91.
25. b) Mikami, K.; Yajima, T.; Terada, M.; Uchimaru, T. Tetrahedron Lett., 1993;34:7591-7194.
26. c) Drumond, D.F.; McMahon, T.B. J. Phys. Chem.,1981;85:3746-3748.
27. [20] Bonnet-Delpon, D.; Bègué, J.P.; Lequeux, T.; Ourévitch, M., Tetrahedron, 1996;52:59-70.
28. [21] Guanti, G.; Banfi, L.;Narisano, E.; Scolastico, C.; Bosone, E. Synthesis, 1985; 609-611.
29. [22] a) Fuchigami, T.; Ichikawa, S.; Kandeel, Z.E.; Konno, A.; Nonaka, T. Heterocycles, 1990;31:415-417.
30. b) Fuchigami, T.; Ichikawa, S. J. Org. Chem, 1994;59:607-615.